This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Samaniego, F. Articles by Wang, S. Search for Related Content PubMed PubMed Citation Articles by Samaniego, F. Articles by Wang, S.

Vascular Endothelial Growth Factor and Kaposi’s Sarcoma Cells in Human Skin Grafts¹

Department of Lymphoma/Myeloma [F. S., C. G., V. P.], Clinical Cancer Prevention, Departments of Clinical Cancer Prevention [F. S., C. G., V. P., D. Y., S. W.] and Pathology [A. S.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 [M. C-S., H. M. D.]; and Ochsner Clinic Foundation, New Orleans, Louisiana 70121 [O. P.]

Human cancer cells often produce tumors in animal models that incompletely reproduce the histology of the parental tumor. Kaposi’s sarcoma (KS) cells, in particular, have not produced durable angiogenic lesions in animal models that resemble those of KS in humans. We investigated the contribution of transformed KS cells, vascular endothelial growth factor (VEGF), and human skin tissue on tumor development in a human skin graft/mouse model. High levels of serum VEGF (322 pg/ml) were seen in HIV-1-infected persons with KS compared with HIV-1-infected persons without KS (115 pg/ml). Human KS lesions expressed VEGF in the spindle cells. Transformed KS cells expressed the mitogenically active 121-amino acid and 165-amino acid isoforms of VEGF. Tumors induced by KS cells implanted in the SCID mice grew preferentially in human skin grafts rather than in ungrafted murine skin. Tumors induced in the presence of human skin grafts developed numerous lumens expressing _vß₃ integrin. KS cells inoculated with neutralizing anti-VEGF antibody did not form tumors. This study supports an important role for VEGF in tumor development and shows how a human tissue can preferentially promote tumor growth.

This article has been cited by other articles:

				O. Prakash, O. R. Swamy, X. Peng, Z.-Y. Tang, L. Li, J. E. Larson, J. C. Cohen, J. Gill, G. Farr, S. Wang, et al. Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis Blood, May 15, 2005; 105(10): 3987 - 3994. [Abstract] [Full Text] [PDF]

				J. Dantal and J.-P. Soulillou Immunosuppressive Drugs and the Risk of Cancer after Organ Transplantation N. Engl. J. Med., March 31, 2005; 352(13): 1371 - 1373. [Full Text] [PDF]

				L. Wang, N. Wakisaka, C. C Tomlinson, S. M DeWire, S. Krall, J. S Pagano, and B. Damania The Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) K1 Protein Induces Expression of Angiogenic and Invasion Factors Cancer Res., April 15, 2004; 64(8): 2774 - 2781. [Abstract] [Full Text] [PDF]

				M. Deguchi, D. Whitaker-Menezes, S. C. Jones, S. Aiba, S. Nakagawa, H. Tagami, R. Korngold, and G. F. Murphy 12E2: A Cloned Murine Dermal Cell with Features of Dermal Dendrocytes and Capacity to Produce Pathologic Changes Resembling Early Kaposi's Sarcoma Am. J. Pathol., November 1, 2003; 163(5): 1817 - 1825. [Abstract] [Full Text] [PDF]